KARA RICHARDSON: Open Payments
NPI 1225200546 · BENTONVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$830 in 40 payments from 10 companies in 2025. Trend: 2023 $1,286 · 2024 $1,429 · 2025 $830
Food & beverage: $830
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $173 |
| ABBVIE INC. | 15 | $170 |
| Lilly USA, LLC | 8 | $170 |
| REVANCE THERAPEUTICS, INC. | 3 | $134 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $33 |
| Janssen Biotech, Inc. | 2 | $32 |
| Incyte Corporation | 1 | $25 |
| Organogenesis Inc. | 1 | $25 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $16 |
Products named: DUPIXENT, DAXXIFY, TALTZ, SKYRIZI, BOTOX, LIBTAYO, EBGLYSS, TREMFYA.
Industry payments across AR — which companies pay providers there.
